{"name":"Exicure, Inc.","slug":"exicure-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":3286000,"netIncome":-4946000,"cash":816000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AST-008","genericName":"AST-008","slug":"ast-008","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AST-008","genericName":"AST-008","slug":"ast-008","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"date":"2026-04-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOaE8tTzhUazl0NnN1VWJYSVdLVzNQOF9HXzN5eTBQUk40djZFd0NlbFhXeTFGSExMQWV4NkZ1VG1qMnkxUmZ2SnR3SzFHUTBEb3pXQldwdWNYWmNnQlNoTXNfUnF0RWV3alZVeW1yT25hUnRva1YxWXEyM1ZNS0pCelotM0lfVk42ZGVKNEFRQmg2WS1GWnZ3cUQ3R1R6dkhUQ1pmendWU2RSN0hqT1p3OUlaaS04c1gzOWdzWG53WE0yNHBVM0ZSdkdqVmtfeE0?oc=5","date":"2026-03-28","type":"pipeline","source":"Minichart","summary":"Exicure, Inc. Files Form 8-K with SEC – Company Info, Stock Symbol XCUR, and NASDAQ Listing Details - Minichart","headline":"Exicure, Inc. Files Form 8-K with SEC – Company Info, Stock Symbol XCUR, and NASDAQ Listing Details","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPWFZGUV9wMWlVcTh0OFZqeE5mc0xyb2JzbEtETGVlOEJUY191SERKS1luR2ZkdjExTjc4RW16dWx5NjZ0b3dPZ1VLejdaWUVyUDFGX0NQSVZ0ZW1PcUVzQTN1VjVlNUQtd0ZJQ0pabEZnM3dKM1VYWjhkNzdYWGxucnF1X3ZUY2xudlJOVGVFWjRFYU5CbG1fUzduX3lIUWJTazdFdTJ0dnZwazE2b0dUMjREa1FrOUZyMmhNWjlsV0w?oc=5","date":"2026-03-27","type":"pipeline","source":"Investing.com","summary":"Exicure director Sangjin Yeo resigns from board and audit committee - Investing.com","headline":"Exicure director Sangjin Yeo resigns from board and audit committee","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNRFdnU1ZyYnVrTC14Tlk0b2t6TmF0aU1wcTdnX01YTU1qNm9UVDZObVpRV0ZGQjFCX2ZyYk1RWUNHS0ZVQktQa2JlM2g2YTg0YWZvSjdfY1VfUFQ0M1JHWFZCeUVEYXUweUdlQWFETjlsZDByekU4cklJUEdfTjZ4cHY5MFNFSHFSLVlBVTNETzRTelN0Y3NmZUhTbWpOdw?oc=5","date":"2026-03-25","type":"trial","source":"openPR.com","summary":"Spinal Muscular Atrophy Clinical Trial Pipeline Expands as 18+ - openPR.com","headline":"Spinal Muscular Atrophy Clinical Trial Pipeline Expands as 18+","sentiment":"neutral"},{"date":"2026-03-25","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQTUxZNTBtaThERFNFQUwzYThGY0FobHhibnZtVnVuZTJhUlNHOWFCeF9DV1JVdVJxX1hxclJMUjBZSzVUbGdUR1VaNEpSMnBwUHRZR29NR1ByTFZ3eWJBZ181ZnZZZDd4X0FfNzlLSHFLUjJtREpNNlRlLS1ZRHRjY0s3YTYzV3RZRHBDdjJ4UDVINHdtQkpqMV9fZC0tTEE0andranNhbXQ?oc=5","date":"2025-12-09","type":"trial","source":"Fierce Biotech","summary":"ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma - Fierce Biotech","headline":"ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma","sentiment":"neutral"},{"date":"2025-11-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQVmxiaXNJcVNPdl92Tko1dWthNDU0c2toLTBKN1pwRWxGQ3dUdVN5bzFZVXQtLTNCWHNoRXNqVTZLYWJTZDRCWV9WakxnaXlXYXNGNUhiWGxTeHdObm5Ba0ZMajRuVWZweWQyeWdSdzE1aXlETFZPSjZnS1hWc19vTEpYNEh4WWN0bkhkRDVzaDdWN0FUV1BWVHRjU0FJd1FtWG9SRUJTNHF2aFFySlVJeVhQN25VclFENEF3d3V5WDZrN2Vxbk9WZEhzUFU?oc=5","date":"2025-08-04","type":"pipeline","source":"Business Wire","summary":"Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements - Business Wire","headline":"Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":0,"period":"2025-12-31"},{"value":500000,"period":"2024-12-31"},{"value":0,"period":"2023-12-31"},{"value":28826000,"period":"2022-12-31"},{"value":-483000,"period":"2021-12-31"},{"value":16613000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":3286000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-4946000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":816000,"cashHistory":[],"totalAssets":14041000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}